Spain
· Delayed Price · Currency is EUR Facephi Biometria Statistics
Total Valuation
Facephi Biometria has a market cap or net worth of EUR 35.67 million. The enterprise value is 45.73 million.
| Market Cap | 35.67M |
| Enterprise Value | 45.73M |
Important Dates
The next estimated earnings date is Friday, September 27, 2024.
| Earnings Date | Sep 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Facephi Biometria has 22.43 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Shares Outstanding | 22.43M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 11.55% |
| Owned by Institutions (%) | 18.42% |
| Float | 19.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.15 |
| PB Ratio | 1.68 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.61 |
| EV / Sales | 1.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -68.80 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 64.67.
| Current Ratio | 0.85 |
| Quick Ratio | 0.85 |
| Debt / Equity | 64.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | -19.50 |
| Interest Coverage | -3.31 |
Financial Efficiency
Return on equity (ROE) is -24.45% and return on invested capital (ROIC) is -12.63%.
| Return on Equity (ROE) | -24.45% |
| Return on Assets (ROA) | -9.08% |
| Return on Capital (ROIC) | -12.63% |
| Revenue Per Employee | 111,075 |
| Profits Per Employee | -16,324 |
| Employee Count | 264 |
| Asset Turnover | 0.75 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.04% in the last 52 weeks. The beta is 1.20, so Facephi Biometria's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -39.04% |
| 50-Day Moving Average | 1.69 |
| 200-Day Moving Average | 1.96 |
| Relative Strength Index (RSI) | 42.65 |
| Average Volume (20 Days) | 7,198 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Facephi Biometria had revenue of EUR 29.32 million and -4.31 million in losses. Loss per share was -0.20.
| Revenue | 29.32M |
| Gross Profit | 25.90M |
| Operating Income | -5.66M |
| Pretax Income | -7.06M |
| Net Income | -4.31M |
| EBITDA | -5.01M |
| EBIT | -5.66M |
| Loss Per Share | -0.20 |
Balance Sheet
The company has 2.90 million in cash and 12.96 million in debt, giving a net cash position of -10.06 million or -0.45 per share.
| Cash & Cash Equivalents | 2.90M |
| Total Debt | 12.96M |
| Net Cash | -10.06M |
| Net Cash Per Share | -0.45 |
| Equity (Book Value) | 20.04M |
| Book Value Per Share | 0.95 |
| Working Capital | -3.29M |
Cash Flow
In the last 12 months, operating cash flow was 853,214 and capital expenditures -1.52 million, giving a free cash flow of -664,633.
| Operating Cash Flow | 853,214 |
| Capital Expenditures | -1.52M |
| Free Cash Flow | -664,633 |
| FCF Per Share | -0.03 |
Margins
Gross margin is 88.32%, with operating and profit margins of -19.31% and -14.70%.
| Gross Margin | 88.32% |
| Operating Margin | -19.31% |
| Pretax Margin | -24.06% |
| Profit Margin | -14.70% |
| EBITDA Margin | -17.08% |
| EBIT Margin | -19.31% |
| FCF Margin | -2.27% |
Dividends & Yields
Facephi Biometria does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.02% |
| Earnings Yield | -12.83% |
| FCF Yield | -1.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |